ATOMWISE
Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn.
ATOMWISE
Industry:
Artificial Intelligence Biotechnology Health Care Machine Learning Medical Pharmaceutical
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.atomwise.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
176.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Apache
Current Advisors List
Current Employees Featured
Founder
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Atomwise
Tencent
Tencent investment in Series B - Atomwise
Sanabil
Sanabil investment in Series B - Atomwise
AME Cloud Ventures
AME Cloud Ventures investment in Series B - Atomwise
DCVC
DCVC investment in Series B - Atomwise
Y Combinator
Y Combinator investment in Series B - Atomwise
Colorcon
Colorcon investment in Series B - Atomwise
Dolby Family Ventures
Dolby Family Ventures investment in Series B - Atomwise
Baidu Ventures
Baidu Ventures investment in Series B - Atomwise
Touchdown Ventures
Touchdown Ventures investment in Series B - Atomwise
Newest Events participated
Key Employee Changes
Date | New article |
---|---|
2022-01-25 | Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments |
Official Site Inspections
http://www.atomwise.com Semrush global rank: 1.46 M Semrush visits lastest month: 18.84 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago